Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Salicylic acid+anthraquinone glycosides 1%/0.5% oral paint |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthraquinone glycoside (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cascara (substance) |
Is a |
True |
Anthraquinone glycoside (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing only anthraquinone glycoside and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Anthraquinone glycoside (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Anthraquinone glycoside (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Anthraquinone glycoside- and salicylic acid-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Anthraquinone glycoside (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing anthraquinone glycoside and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Anthraquinone glycoside (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
Has precise active ingredient |
True |
Anthraquinone glycoside (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
Has basis of strength substance (attribute) |
True |
Anthraquinone glycoside (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |